logo
Isleton City Council structure shaken up, meeting turns to chaos

Isleton City Council structure shaken up, meeting turns to chaos

CBS News6 hours ago
There's political drama in the Delta, after the Isleton City Council ousted the mayor as part of a reorganization, naming a new mayor and vice mayor from within the council.
Tensions were high at a chaotic meeting on Tuesday, where CBS Sacramento's camera was rolling.
As the meeting went on, insults, opinions, and frustrations were shared by councilmembers, city staff, and members of the public who were in attendance in a packed city hall.
Expletives were regularly thrown into comments and grievances from all sides. At the center of one of the most contested items was the now-former mayor, Iva Walton.
Walton was accused of continuing to operate an outdoor dining area at her bar, Mei Wah Beer Room, after her encroachment permit was denied. At one point, Walton said: "It feels like dumping when her [councilmember Aleida Suarez] wife calls me a 'bad dog.' "
Suarez responded: "You call us coffee b-----," adding, "this isn't about he said she said. This is about code of conduct."
At times, other members of the public blurted out expletives as councilmembers spoke to each other, at times, outlining negative or untrue social media posts made about each other.
Isleton has a $4.7 million debt, and a recent grand jury report outlined systemic issues that put the city on the brink of bankruptcy. Tuesday night, before chaos erupted, the council voted to send a letter of request to the Sacramento County Board of Supervisors requesting an $800,000 loan to address some of their immediate debts.
Members of the public expressed concern amid the tense exchanges and council upheaval that the perception of their city may be impacted if they receive the county loan.
"We just have to look at the future and how the person that's going to give us a loan and looks at what you guys are doing now. There's a TV camera here, there's a reporter here. How do you want to look to the public?" one speaker said.
CBS Sacramento took the concerns about the impacts of the meeting to the city's acting finance director, who said on Wednesday that the city manager spent most of the day doing "damage control."
"Change is going to be painful. This city has operated for one way for decades. To put them on the right path, it's going to look really rocky," said Jessica Bigby, acting finance director of Isleton.
The now-mayor, David Kent, told CBS Sacramento it was good to get all of the thoughts, feelings, and opinions out in the open.
"A bit of a deviation of sort of the standard session you would expect, but it was healthy and necessary in my opinion," said Kent.
In a statement to CBS13, Walton said she believed the proper procedure was not followed, "and the complaints were largely personal attacks and had nothing to do with the leadership I brought to the chair/mayor council position."
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Biotricity Reinforces Growth Trajectory, Kicking Off Fiscal 2026 with Strong First Quarter Results Featuring Revenue Growth, Positive EBITDA and Improved Margins
Biotricity Reinforces Growth Trajectory, Kicking Off Fiscal 2026 with Strong First Quarter Results Featuring Revenue Growth, Positive EBITDA and Improved Margins

Yahoo

time17 minutes ago

  • Yahoo

Biotricity Reinforces Growth Trajectory, Kicking Off Fiscal 2026 with Strong First Quarter Results Featuring Revenue Growth, Positive EBITDA and Improved Margins

REDWOOD CITY, CA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY) ("Biotricity" or the "Company'), an innovative Technology-as-a-Service (TaaS) company committed to redefining the landscape of the healthcare industry with state-of-the-art remote monitoring and diagnostic solutions, today announced its financial results for its first quarter of fiscal 2026, ended June 30, 2025. Dr. Waqaas Al-Siddiq, Biotricity Founder & CEO, said, "We're proud to deliver another quarter of strong performance and a shift to positive EBITDA, which demonstrates the scalability of our business model and strength of our team. Management believes that this a foundational milestone for Biotricity, exemplifying our ability to grow our business as we go from a loss-producing startup to a business that can operate profitably. Following a massive year of positive transformation for Biotricity, we continue to harness the power of workflow automation, AI technology, and other technological enhancements to further improve our operational expenses, margins, and revenues. This powerful combination has set the foundation to fuel ongoing growth. In doing so, we demonstrate our ability to scale with strategic focus and long-term sustainability. The expansion of our Cardiac AI Cloud platform, empowered by strategic partnerships with industry giants, showcases our commitment to revolutionizing medical diagnostics and consumer healthcare. Leveraging over 2 trillion beats of anonymized data, our AI-driven platform is set to enhance clinic profitability, paving the way for transformative advancements in diagnostic accuracy and patient outcomes. Importantly, we remain on track to pursue FDA clearance for our groundbreaking AI clinical model in the coming months. Strategic alliances forged during fiscal 2025 and 2026 have positioned us to capitalize on expansive market channels, providing access to approximately 90% of all hospitals in America and opening the door to managed care programs, which is a new vertical strategy for Biotricity. These developments mark a significant leap forward in our mission to deliver innovative, accessible, and high-quality cardiac care solutions." Q1-FY26 Financial Highlights Revenue increased 21% to $3.9 million, compared with $3.2 million in Q4 FY24 Gross margin was 80.5% for the three months ended June 30, 2025, as compared to 73.8% in the corresponding prior year quarter; this is the result of expansion in the recurring technology fee revenue base, efficiencies gained in using proprietary AI in operational automation, and improvement in monitoring and cloud cost structure. Net loss decreased to $0.75 million, or $0.03 per share, from a net loss of $6.9 million, or $0.49 per share, in Q1-FY25; this was an 80.6% improvement even after removing the effects of a $3 million one-time deemed dividend in the corresponding prior year period. Positive EBITDA of $333,337, first time in the Company's history; EBITDA increased by 118.7% compared to corresponding prior year quarter; this is the result of growth and operating efficiencies. Operating Highlights for Q1-FY26 and the Future Q1-FY26 recurring (TaaS) Technology Fees rose a robust 11.8% from the corresponding period of the prior year, to $3.4 million, which is also 7.9% increase from the immediately preceding three-month period. Company maintained its track record of strong customer retention, supported by the quality of customer and physician-friendly support services which emphasize the accuracy of our diagnostics and ease-of-use of our solution. Leveraging on its adept development of a range of state-of-the-art products to service a total addressable market of $35 billion. Working on achieving regulatory approval in internation markets, with a view to laying the foundation for distribution in those markets in the coming years, after successfully achieving approvals in Canada, Saudi Arabia and Argentina. Expansion of geographic footprint across 70% of the US, with penetration across thousands of physicians over hundreds of centers, including those acquired through relationships with strategic partners. Secured strategic alliances with three of the top GPOs representing 90% of all hospitals in the US. Full details of the Company's financial results will be filed with the SEC on Form 10-Q and available by visiting Financial Results and Business Update Conference Call Management will host a conference call on Thursday August 14, 2025 at 4:30 p.m. ET to discuss its financial results for fiscal first quarter of 2026 and provide a business update. Additional details are available under the Investor Relations section of the Company's website: Event: Biotricity First Quarter Fiscal 2026 Financial Results and Business Update CallDate: Thursday, August 14, 2025Time: 4:30pm ET (1:30pm PT) Toll Free: 1-877-269-7751 International: 1-201-389-0908 Webcast URL: Investors can begin accessing the webcast 15 minutes before the call, where an operator will register your name and organization. The call will be in listen-only mode. A replay of the call will be available approximately three hours after the live call via the Investors section of the Biotricity website at Toll Free Replay Number: 1-844-512-2921 International: 1-412-317-6671 Replay Access ID: 13755374Expiration: Thursday, August 28, 2025 at 11:59 PM ET About Biotricity Inc. Biotricity is reforming the healthcare market by bridging the gap in remote monitoring and chronic care management. Doctors and patients trust Biotricity's unparalleled standard for preventive & personal care, including diagnostic and post-diagnostic solutions for chronic conditions. The Company develops comprehensive remote health monitoring solutions for the medical and consumer markets. To learn more, visit Non-GAAP Measures Non-GAAP financial information presented may be determined or calculated differently by other companies and may not be directly comparable to that of other companies. It is management's intent to provide non-GAAP financial information to enhance the understanding of Biotricity's GAAP financial information, and it should be considered by the reader in addition to, but not instead of, the financial statements prepared in accordance with GAAP. We believe that providing these non-GAAP measures in addition to the GAAP measures allows management, investors and other users of our financial information to more fully and accurately assess business performance. Earnings before interest, tax, depreciation and amortization ('EBITDA') is one such measure: 3 months endedJune 30,2025 3 months endedJune 30,2024 $ $ Net loss attributable to common stockholders (754,293 ) (6,948,292 ) Add: Provision for income taxes - - Interest expense 850,254 768,673 Accretion and amortization expenses 153,572 1,144,728 Depreciation 1,488 1,488 Preferred stock dividends 82,316 3,253,772 EBITDA 333,337 (1,779,631 ) Weighted average number of common shares outstanding 26,284,734 14,169,441 Profit (Loss) per Share, Basic and Diluted 0.013 (0.126 ) Important Cautions Regarding Forward-Looking Statements Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Forward-looking statements, which involve assumptions and describe our future plans, strategies, and expectations, are generally identifiable by use of the words "may," "should," "would," "will," "could," "scheduled," "expect," "anticipate," "estimate," "believe," "intend," "seek," "project," or "goal" or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements may include, without limitation, statements regarding (i) the plans, objectives and goals of management for future operations, including plans, objectives or goals relating to the design, development and commercialization of Bioflux or any of the Company's other proposed products or services, (ii) a projection of income (including income/loss), earnings (including earnings/loss) per share, capital expenditures, dividends, capital structure or other financial items, (iii) the Company's future financial performance, (iv) the regulatory regime in which the Company operates or intends to operate and (v) the assumptions underlying or relating to any statement described in points (i), (ii), (iii) or (iv) above. Such forward-looking statements are not meant to predict or guarantee actual results, performance, events or circumstances and may not be realized because they are based upon the Company's current projections, plans, objectives, beliefs, expectations, estimates and assumptions and are subject to a number of risks and uncertainties and other influences, many of which the Company has no control over. Actual results and the timing of certain events and circumstances may differ materially from those described by the forward-looking statements as a result of these risks and uncertainties. Factors that may influence or contribute to the inaccuracy of the forward-looking statements or cause actual results to differ materially from expected or desired results may include, without limitation, the Company's inability to obtain additional financing, the significant length of time and resources associated with the development of its products and related insufficient cash flows and resulting illiquidity, the Company's inability to expand the Company's business, significant government regulation of medical devices and the healthcare industry, lack of product diversification, existing or increased competition, results of arbitration and litigation, stock volatility and illiquidity, and the Company's failure to implement the Company's business plans or strategies. These and other factors are identified and described in more detail in the Company's filings with the SEC. The Company assumes no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release. Contacts Investor RelationsBiotricity Investor RelationsInvestors@ SOURCE: Biotricity Inc.

Madison Street Capital Acts as Exclusive Financial Advisor to American Anchor Bolt Mfg. ("American Anchor Bolt") in its Sale to Salt Creek Capital
Madison Street Capital Acts as Exclusive Financial Advisor to American Anchor Bolt Mfg. ("American Anchor Bolt") in its Sale to Salt Creek Capital

Yahoo

time17 minutes ago

  • Yahoo

Madison Street Capital Acts as Exclusive Financial Advisor to American Anchor Bolt Mfg. ("American Anchor Bolt") in its Sale to Salt Creek Capital

AUSTIN, Texas, Aug. 14, 2025 /PRNewswire/ -- Madison Street Capital and its broker-dealer MSC-BD (MSC), an international investment banking firm, acted as the exclusive advisor in the sale of American Anchor Bolt to Salt Creek Capital, a private equity firm based in Woodside, CA. Founded in 1996 by Myrna Tucker and headquartered in Houston, TX, American Anchor Bolt produces customized anchor bolts and embedded steel products. The transaction was announced by Charles Botchway, CEO of Madison Street Capital, and led by Managing Director Peter Phillips. Terms of the transaction were not disclosed. "We are proud to have represented American Anchor Bolt in this transaction. This further demonstrates MSC's continued expertise in the industrials space. Pete Phillips and team worked tirelessly on its behalf, and we wish American Anchor Bolt much continued success," said Charles Botchway, CEO of Madison Street Capital. "I truly do not believe my deal would have come into fruition without Madison Street Capital driving the process. Starting with the appealing graphics that presented my business in a comprehensive and attention-grabbing light, to the real-world explanations of what was most important to consider with each decision, MSC shined," said Myrna Tucker, President of American Anchor Bolt. "Pete was the ship captain that kept all things heading in the right direction – he even talked me off the ledge a few times. Daniel kept us organized. He broke down the 'to-do' lists into manageable bites and patiently kept me on track. Together they moved me toward my goal. MSC was a valuable team to have on my side during what may have been one of the most important journeys of my life." "Led by founder Myrna Tucker, American Anchor Bolt is the prototypical MSC client – a 'Main Street', owner-operated industry leader that dominates a market niche. Myrna's journey is an amazing, classically American story – from seizing an opportunity to run her own business, to becoming trusted supplier for the world's most complex and extensive Engineering & Construction projects," said Pete Philips, Managing Director, Madison Street Capital. "Myrna was as pleasant to work with as any client I've had in the past, yet underneath her external demeanor is a gritty, shrewd businesswoman who knows how to win. We are very happy to have been able to deliver her a result and believe that the team at Salt Creek Capital has a home run on their hands." About Madison Street CapitalMadison Street Capital, an international investment bank with expertise in mergers and acquisitions, is committed to integrity, excellence, leadership, and service in delivering corporate financial advisory services, sell-side representation, financial opinions, and valuation services to publicly and privately held businesses. These services position our clients to succeed in the global marketplace. In undertaking each new project, the client's goals and objectives become ours, ranging from financial advisory and successful capital raises to M&A transactions to transfers of ownership. Our firm has earned the trust of clients around the world through our unwavering dedication to the highest levels of professional standards. For more information, please visit About American Anchor Bolt 1996, American Anchor Bolt is a premier producer of custom anchor bolts and embedded steel. Known as one of the fastest, lowest cost suppliers in the industry, all production takes place at its 21,000 square foot facility in Houston, TX. American Anchor Bolt offers threading capacity through 4" and bending up to 4 ¼" bolts. To learn more, visit About Salt Creek CapitalFounded in 2009, Salt Creek Capital is a private investment firm providing flexible capital solutions to entrepreneurs and family-owned businesses. For over 15 years, we have specialized in ownership transitions as the first institutional partner for businesses generating up to $100M in annual sales. For additional information, visit For Media InquiriesDebora Lima, Head of PR, pr@ For Investment Banking InquiriesKevin Owen, Director of Deal Origination, (941) 250-3613 kjowen@ View original content to download multimedia: SOURCE Madison Street Capital Sign in to access your portfolio

PennyMac Mortgage Investment Trust Declares Third Quarter 2025 Dividends for Its Preferred Shares
PennyMac Mortgage Investment Trust Declares Third Quarter 2025 Dividends for Its Preferred Shares

Yahoo

time17 minutes ago

  • Yahoo

PennyMac Mortgage Investment Trust Declares Third Quarter 2025 Dividends for Its Preferred Shares

WESTLAKE VILLAGE, Calif., August 14, 2025--(BUSINESS WIRE)--PennyMac Mortgage Investment Trust (NYSE: PMT) announced today that its Board of Trustees has declared cash dividends for the third quarter of 2025 on its 8.125% Series A Preferred Shares (NYSE: PMT PRA), its 8.000% Series B Preferred Shares (NYSE: PMT PRB) and its 6.750% Series C Preferred Shares (NYSE: PMT PRC). In accordance with the terms for each preferred series, the dividend information is as follows: Series Ticker AnnualDividend Rate Dividend PerShare Record Date Payment Date A PMT PRA 8.125% $0.507813 September 1, 2025* September 15, 2025 B PMT PRB 8.000% $0.500000 September 1, 2025* September 15, 2025 C PMT PRC 6.750% $0.421875 September 1, 2025* September 15, 2025 *As September 1, 2025 falls on a federal holiday, the effective record date for these dividends will be Friday, August 29, 2025 About PennyMac Mortgage Investment Trust PennyMac Mortgage Investment Trust is a mortgage real estate investment trust (REIT) that invests primarily in residential mortgage loans and mortgage-related assets. PMT is externally managed by PNMAC Capital Management, LLC, a wholly-owned subsidiary of PennyMac Financial Services, Inc. (NYSE: PFSI). Additional information about PennyMac Mortgage Investment Trust is available at Shop Top Mortgage Rates Your Path to Homeownership A quicker path to financial freedom Personalized rates in minutes Forward-Looking Statements This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, regarding management's beliefs, estimates, projections and assumptions with respect to, among other things, PennyMac Mortgage Investment Trust's (the "Company") financial results, future operations, business plans and investment strategies, as well as industry and market conditions, all of which are subject to change. Words like "believe," "expect," "anticipate," "promise," "plan," and other expressions or words of similar meanings, as well as future or conditional verbs such as "will," "would," "should," "could," or "may" are generally intended to identify forward-looking statements. Actual results and operations for any future period may vary materially from those projected herein and from past results discussed herein. Factors which could cause actual results to differ materially from historical results or those anticipated include, but are not limited to: changes in interest rates; the Company's ability to comply with various federal, state and local laws and regulations that govern its business; volatility in the Company's industry, the debt or equity markets, the general economy or the real estate finance and real estate markets; events or circumstances which undermine confidence in the financial and housing markets or otherwise have a broad impact on financial and housing markets; changes in real estate values, housing prices and housing sales; changes in macroeconomic, consumer and real estate market conditions; the degree and nature of the Company's competition; the availability of, and level of competition for, attractive risk-adjusted investment opportunities in mortgage loans and mortgage-related assets that satisfy the Company's investment objectives; the inherent difficulty in winning bids to acquire mortgage loans, and the Company's success in doing so; the concentration of credit risks to which the Company is exposed; the Company's dependence on and potential conflicts with its manager, servicer and their affiliates; the Company's ability to mitigate cybersecurity risks, cybersecurity incidents and technology disruptions; the development of artificial intelligence; the availability, terms and deployment of short term and long term capital; the adequacy of the Company's cash reserves and working capital; the Company's ability to maintain the desired relationship between its financing and the interest rates and maturities of its assets; the timing and amount of cash flows, if any, from the Company's investments; the Company's substantial amount of indebtedness; the performance, financial condition and liquidity of borrowers; the Company's exposure to risks of loss and disruptions in operations resulting from severe weather events, man-made or other natural conditions, including climate change and pandemics; the ability of the Company's servicer, which also provides the Company with fulfillment services, to approve and monitor correspondent sellers and underwrite loans to investor standards; incomplete or inaccurate information or documentation provided by customers or counterparties, or adverse changes in the financial condition of the Company's customers and counterparties; the Company's indemnification and repurchase obligations in connection with mortgage loans it purchases, sells or securitizes; the quality and enforceability of the collateral documentation evidencing the Company's ownership and rights in the assets in which it invests; increased rates of delinquency, defaults and forbearances and/or decreased recovery rates on the Company's investments; the performance of mortgage loans underlying mortgage-backed securities in which the Company retains credit risk; the Company's ability to foreclose on its investments in a timely manner or at all; increased prepayments of the mortgages and other loans underlying the Company's mortgage-backed securities or relating to the Company's mortgage servicing rights and other investments; risks associated with the discontinuation of LIBOR; the degree to which the Company's hedging strategies may or may not protect it from interest rate volatility; the effect of the accuracy of or changes in the estimates the Company makes about uncertainties, contingencies and asset and liability valuations when measuring and reporting upon the Company's financial condition and results of operations; the Company's ability to maintain appropriate internal control over financial reporting; the Company's ability to detect misconduct and fraud; 9 developments in the secondary markets for the Company's mortgage loan products; legislative and regulatory changes that impact the mortgage loan industry or housing market; regulatory or other changes that impact government agencies or government-sponsored entities, or such changes that increase the cost of doing business with such agencies or entities; federal and state mortgage regulations and enforcement; changes in government support of homeownership; changes in government or government-sponsored home affordability programs; changes in the Company's investment objectives or investment or operational strategies, including any new lines of business or new products and services that may subject it to additional risks; limitations imposed on the Company's business and its ability to satisfy complex rules for it to qualify as a REIT for U.S. federal income tax purposes and qualify for an exclusion from the Investment Company Act of 1940 and the ability of the Company's subsidiaries to qualify as REITs or as taxable REIT subsidiaries for U.S. federal income tax purposes; changes in governmental regulations, accounting treatment, tax rates and similar matters; the Company's ability to make distributions to its shareholders in the future; the Company's failure to deal appropriately with issues that may give rise to reputational risk; and the Company's organizational structure and certain requirements in its charter documents. You should not place undue reliance on any forward-looking statement and should consider all of the uncertainties and risks described above, as well as those more fully discussed in reports and other documents filed by the Company with the Securities and Exchange Commission from time to time. The Company undertakes no obligation to publicly update or revise any forward-looking statements or any other information contained herein, and the statements made in this press release are current as of the date of this release only. View source version on Contacts Media Kristyn Clarkmediarelations@ 805.395.9943 Investors Kevin ChamberlainIsaac Gardeninvestorrelations@ 818.224.7028 Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store